Literature DB >> 16485898

Genomic identification of potential risk factors during acetaminophen-induced liver disease in susceptible and resistant strains of mice.

Kevin D Welch1, Timothy P Reilly, Mohammed Bourdi, Thomas Hays, Cynthia A Pise-Masison, Michael F Radonovich, John N Brady, David J Dix, Lance R Pohl.   

Abstract

Drug-induced liver disease (DILD) continues to cause significant morbidity and mortality and impair new drug development. Mounting evidence suggests that DILD is a complex, multifactorial disease in which no one factor is likely to be an absolute indicator of susceptibility. As an approach to better understand the multifactorial basis of DILD, we recently compared the hepatic proteomes of mice that were resistant (SJL) and susceptible (C57Bl/6) to APAP-induced liver disease (AILD) wherein we identified potential risk factors and mechanistic pathways responsible for DILD. In this study, we have uncovered additional potential risk factors by comparing hepatic mRNA expression profiles of the same two strains of mice with that of SJLxB6-F1 hybrid (F1) mice, which were found to be of intermediate susceptibility to AILD. Global hepatic gene expression profiling over a 24 h period following APAP treatment revealed elevated patterns in the mRNA expression of cytoprotective genes in resistant SJL mice as compared to susceptible B6 mice, while F1 mice had intermediate mRNA expression levels of these genes. One of these genes encoded for heat shock protein (HSP) 70 whose relative protein expression among the three strains of mice was found to parallel that of their mRNA levels, suggesting that this protein had a protective role against AILD. However, there was no difference in the susceptibility of HSP70 knockout (KO) mice to AILD as compared to wild-type (WT) mice. There were also protoxicant genes, such as osteopontin (OPN), with elevated mRNA expression levels in the B6 mice as compared to the SJL mice and with intermediate levels in the F1 mice, suggesting that they may play a role in exacerbating liver injury after APAP treatment. In support of this hypothesis, OPN KO mice were found to be more resistant to AILD than WT mice. Additionally, the results from both the proteomic and the genomic studies were compared. The two approaches were found to be complementary to each other and not simply overlapping. Our findings suggest that comparative gene expression analysis of susceptible and resistant mouse strains may lead to the identification of factors that could have a role in determining the susceptibility of individuals to DILD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16485898     DOI: 10.1021/tx050285z

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  14 in total

1.  The dual role of osteopontin in acetaminophen hepatotoxicity.

Authors:  Chun-yan He; Bei-bei Liang; Xiao-yu Fan; Lei Cao; Rui Chen; Ya-jun Guo; Jian Zhao
Journal:  Acta Pharmacol Sin       Date:  2012-06-25       Impact factor: 6.150

Review 2.  Mechanisms of acetaminophen-induced liver necrosis.

Authors:  Jack A Hinson; Dean W Roberts; Laura P James
Journal:  Handb Exp Pharmacol       Date:  2010

3.  Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.

Authors:  Devanshi Seth; Alastair Duly; Paul C Kuo; Geoffrey W McCaughan; Paul S Haber
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Drug-induced liver injury.

Authors:  Gebran Abboud; Neil Kaplowitz
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis).

Authors:  Gerritje J W van der Windt; W Joost Wiersinga; Catharina W Wieland; Ivo C S I Tjia; Nicholas P Day; Sharon J Peacock; Sandrine Florquin; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

6.  The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice.

Authors:  Brittany V Martin-Murphy; Michael P Holt; Cynthia Ju
Journal:  Toxicol Lett       Date:  2009-12-01       Impact factor: 4.372

7.  Plasminogen activator inhibitor-1 limits liver injury and facilitates regeneration after acetaminophen overdose.

Authors:  Mary Lynn Bajt; Hui-Min Yan; Anwar Farhood; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2008-05-09       Impact factor: 4.849

8.  S-adenosyl-l-methionine protection of acetaminophen mediated oxidative stress and identification of hepatic 4-hydroxynonenal protein adducts by mass spectrometry.

Authors:  James Mike Brown; Christopher Kuhlman; Marcus V Terneus; Matthew T Labenski; Andre Benja Lamyaithong; John G Ball; Serrine S Lau; Monica A Valentovic
Journal:  Toxicol Appl Pharmacol       Date:  2014-09-22       Impact factor: 4.219

9.  Identification and categorization of liver toxicity markers induced by a related pair of drugs.

Authors:  Ching-Wei Chang; Frederick A Beland; Wade M Hines; James C Fuscoe; Tao Han; James J Chen
Journal:  Int J Mol Sci       Date:  2011-07-15       Impact factor: 5.923

10.  p53 Contributes to Differentiating Gene Expression Following Exposure to Acetaminophen and Its Less Hepatotoxic Regioisomer Both In Vitro and In Vivo.

Authors:  Brendan D Stamper; Michael L Garcia; Duy Q Nguyen; Richard P Beyer; Theo K Bammler; Frederico M Farin; Terrance J Kavanagh; Sidney D Nelson
Journal:  Gene Regul Syst Bio       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.